{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:15:38Z","timestamp":1778580938409,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Workplace drug testing aims to deter employees from abusing drugs. Nevertheless, people try to beat such tests in several ways. Therefore, it is important for drug-testing laboratories to identify adulterated specimens before analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A literature search on beating drug tests, urine adulteration, flushing agents, detoxifying agents, and Internet-based adulterants, published in English from 1986 to present, was conducted using PubMed, ScienceDirect, Scopus, Web of Science, and ResearchGate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>People try to beat drug testing in two ways: by ingesting detoxifying agents to wash out abused drugs or by adding adulterants (household chemicals or Internet-based chemicals) to urine in vitro. However, drug-testing laboratories conduct specimen validity tests (pH, creatinine, specific gravity, and temperature tests) and specialized tests to identify adulterants, such as potassium nitrite, glutaraldehyde, pyridinium chlorochromate, and oxidants in urine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>By combining specimen integrity and specialized tests to detect adulterants, laboratory staff can identify adulterated urine specimens before analytical testing. As such adulterated specimens are considered equivalent to refusal to undergo drug testing, individuals that altered their samples fail the test. Nevertheless, workplace drug-testing programs have limitations, including the inability to target novel psychoactive drugs in the test protocol and the inability to detect newly introduced urinary adulterants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001360","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T20:02:05Z","timestamp":1752782525000},"page":"283-294","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Beating Drug Tests by Ingesting Detoxifying Agents or Adulterating Urine in vitro: Are These Practices Effective?"],"prefix":"10.1097","volume":"48","author":[{"given":"Amitava","family":"Dasgupta","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"suppl 2","key":"R2-20260508","first-page":"S10","article-title":"The epidemiology of drug abuse","volume":"61","author":"Ignaszewski","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"R3-20260508","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/injuryprev-2018-043104","article-title":"Drug overdose deaths at work, 2011-2016","volume":"25","author":"Tiesman","year":"2019","journal-title":"Inj Prev"},{"key":"R4-20260508","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1475-6773.2006.00632.x","article-title":"Workplace drug testing and worker drug use","volume":"42","author":"Carpenter","year":"2007","journal-title":"Health Serv Res"},{"key":"R5-20260508","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.aap.2014.05.012","article-title":"How effective is drug testing as a workplace safety strategy? A systematic review of the evidence","volume":"71","author":"Pidd","year":"2014","journal-title":"Accid Anal Prev"},{"key":"R6-20260508","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jfda.2017.01.001","article-title":"Urine specimen validity test for drug abuse testing in workplace and court settings","volume":"26","author":"Lin","year":"2018","journal-title":"J Food Drug Anal"},{"key":"R7-20260508","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jat\/29.7.658","article-title":"Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI)","volume":"29","author":"Paul","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R8-20260508","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jat\/29.5.275","article-title":"Papain: a novel urine adulterant","volume":"29","author":"Burrows","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R9-20260508","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jat\/32.6.438","article-title":"Papain adulteration in 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid-positive urine samples","volume":"32","author":"Larson","year":"2008","journal-title":"J Anal Toxicol"},{"key":"R10-20260508","first-page":"38","article-title":"A practical guide to urine drug monitoring","volume":"35","author":"Raouf","year":"2018","journal-title":"Fed Pract"},{"key":"R11-20260508","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00129334-200111000-00013","article-title":"Biophysical effects of water and synthetic urine on skin","volume":"14","author":"Mayrovitz","year":"2001","journal-title":"Adv Skin Wound Care"},{"key":"R12-20260508","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1515\/CCLM.2004.107","article-title":"Urine labeling with orally applied marker substances in drug substitution therapy","volume":"42","author":"Huppertz","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R13-20260508","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FTD.0000000000001127","article-title":"Matrix effects of urine marker substances in LC-MS\/MS analysis of drug of abuse","volume":"46","author":"Huppertz","year":"2024","journal-title":"Ther Drug Monit"},{"key":"R14-20260508","first-page":"1","article-title":"Application of serological and DNA methods for the identification of urine specimen donors","volume":"5","author":"Hplland","year":"1993","journal-title":"Forensic Sci Rev"},{"key":"R15-20260508","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/dta.3709","article-title":"Individual identification method using samples associated with doping tests: a comparison of mitochondrial and nuclear genetic data","volume":"17","author":"Akiyama","year":"2025","journal-title":"Drug Test Anal"},{"key":"R16-20260508","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/dta.2497","article-title":"Can synthetic urine replace authentic urine to \u201cbeat\u201d workplace drug testing?","volume":"11","author":"Kim","year":"2019","journal-title":"Drug Test Anal"},{"key":"R17-20260508","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jat\/bkac029","article-title":"Update on urine adulterants and synthetic urine samples to subvert urine drug testing","volume":"46","author":"Vikingsson","year":"2022","journal-title":"J Anal Toxicol"},{"key":"R19-20260508","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1360-0443.1995.tb03505.x","article-title":"An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening","volume":"90","author":"George","year":"1995","journal-title":"Addiction"},{"key":"R20-20260508","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1520\/JFS13298J","article-title":"Creatinine analysis in single collection urine specimens","volume":"37","author":"Needleman","year":"1992","journal-title":"J Forensic Sci"},{"key":"R21-20260508","first-page":"703","article-title":"Adulteration of urine drug testing-an exaggerated cause of concern","volume":"97","author":"Beck","year":"2000","journal-title":"Lakartidningen"},{"key":"R22-20260508","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00007691-200312000-00011","article-title":"Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators","volume":"25","author":"Fraser","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R23-20260508","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1373\/clinchem.2003.028878","article-title":"Analytic performance of immunoassays for drugs of abuse below established cutoff values","volume":"50","author":"Luzzi","year":"2004","journal-title":"Clin Chem"},{"key":"R24-20260508","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jat\/26.7.419","article-title":"The defined HHS\/DOT substituted urine criteria validated through a controlled hydration study","volume":"26","author":"Edgell","year":"2002","journal-title":"J Anal Toxicol"},{"key":"R25-20260508","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jat\/26.7.424","article-title":"Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS\/DOT criteria","volume":"26","author":"Cook","year":"2002","journal-title":"J Anal Toxicol"},{"key":"R26-20260508","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jat\/22.6.460","article-title":"In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results","volume":"22","author":"Cone","year":"1998","journal-title":"J Anal Toxicol"},{"key":"R27-20260508","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/clinchem\/34.11.2333","article-title":"Adulterants causing false negatives in illicit drug testing","volume":"34","author":"Mikkelsen","year":"1988","journal-title":"Clin Chem"},{"key":"R28-20260508","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/np049868j","article-title":"A new glucosyl feruloyl quinic acid as a potential marker for roots and rhizomes of goldenseal, Hydrastis canadensis","volume":"67","author":"McNamara","year":"2004","journal-title":"J Nat Prod"},{"key":"R29-20260508","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/bmc.201","article-title":"Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry","volume":"16","author":"Deventer","year":"2002","journal-title":"Biomed Chromatogr"},{"key":"R30-20260508","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/clinchem\/35.4.648","article-title":"Interference of common household chemicals in immunoassay methods for drugs of abuse","volume":"35","author":"Warner","year":"1989","journal-title":"Clin Chem"},{"key":"R31-20260508","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/FQY06F8XKTQPM149","article-title":"The effect of adulterants and selected ingested compounds on drugs of abuse testing in urine","volume":"228","author":"Dasgupta","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R32-20260508","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jat\/25.7.572","article-title":"Analysis of morphine and codeine in samples adulterated with Stealth","volume":"25","author":"Cody","year":"2001","journal-title":"J Anal Toxicol"},{"key":"R33-20260508","first-page":"111","article-title":"A procedure for the detection of Stealth adulterant in urine samples","volume":"15","author":"Valtier","year":"2002","journal-title":"Clin Lab Sci"},{"key":"R34-20260508","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/clinchem\/45.7.1051","article-title":"Adulteration of urine by \u201curine Luck.\u201d","volume":"45","author":"Wu","year":"1999","journal-title":"Clin Chem"},{"key":"R35-20260508","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jat\/20.3.195","article-title":"The effect of glutaraldehyde adulteration of urine specimens on syva EMIT II drugs-of-abuse assays","volume":"20","author":"George","year":"1996","journal-title":"J Anal Toxicol"},{"key":"R36-20260508","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jat\/21.3.240","article-title":"A procedure to overcome interferences caused by the adulterant \u201cKlear\u201d in the GC-MS analysis of 11-nor-\u03949-THC-9-COOH","volume":"20","author":"ElSohly","year":"1997","journal-title":"J Anal Toxicol"},{"key":"R37-20260508","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jat\/22.6.474","article-title":"Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry","volume":"22","author":"Tsai","year":"1998","journal-title":"J Anal Toxicol"},{"key":"R38-20260508","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jat\/22.2.89","article-title":"Nitrite adulteration of workplace urine drug-testing specimens. I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration","volume":"22","author":"Urry","year":"1998","journal-title":"J Anal Toxicol"},{"key":"R39-20260508","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/anatox\/35.6.333","article-title":"Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing","volume":"35","author":"Venkatratnam","year":"2011","journal-title":"J Anal Toxicol"},{"key":"R40-20260508","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1309\/AJCP2FJ9VBPXJYTQ","article-title":"Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing","volume":"140","author":"Welsh","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R41-20260508","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jat\/23.1.72","article-title":"Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing","volume":"23","author":"King","year":"1999","journal-title":"J Anal Toxicol"},{"key":"R42-20260508","first-page":"550","article-title":"Comparison of different methods used in drugs of abuse for sample validity testing including pH methods, specific gravity methods, TECO\u2122 Drug Adulteration Test Strip and oxidant assay","volume":"2","author":"Mina","year":"2021","journal-title":"Adv Lab Med"},{"key":"R43-20260508","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/dta.2481","article-title":"Suitability evaluation of new endogenous biomarkers for the identification of nitrite-based urine adulteration in mass spectrometry methods","volume":"11","author":"Steuer","year":"2019","journal-title":"Drug Test Anal"},{"key":"R44-20260508","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1515\/cclm-2021-0010","article-title":"Interpretable machine learning model to detect chemically adulterated urine samples analyzed by high resolution mass spectrometry","volume":"59","author":"Streun","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"R45-20260508","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.1002\/anr3.12130","article-title":"Acute cardiotoxicity following 'poppy seed tea' consumption","volume":"9","author":"Tan","year":"2021","journal-title":"Anaesth Rep"},{"key":"R46-20260508","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000508446","article-title":"Maternal poppy seed tea ingestion and ensuing neonatal abstinence syndrome","volume":"117","author":"Garcia","year":"2020","journal-title":"Neonatology"},{"key":"R47-20260508","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0379-0738(91)90171-E","article-title":"Urinary excretion of benzoylecgonine following ingestion of Health Inca tea","volume":"49","author":"Jackson","year":"1991","journal-title":"Forensic Sci Int"},{"key":"R48-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bku116","article-title":"Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results","volume":"39","author":"Cone","year":"2015","journal-title":"J Anal Toxicol"},{"key":"R49-20260508","doi-asserted-by":"crossref","first-page":"110810","DOI":"10.1016\/j.clinbiochem.2024.110810","article-title":"New psychoactive substances: a Canadian perspective on emerging trends and challenges for the clinical laboratory","volume":"133-134","author":"Miller","year":"2024","journal-title":"Clin Biochem"},{"key":"R50-20260508","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R51-20260508","doi-asserted-by":"crossref","first-page":"102045125320967197","DOI":"10.1177\/2045125320967197","article-title":"New psychoactive substances: a review and updates","volume":"10","author":"Shafi","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"R52-20260508","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-022-03224-2","article-title":"Developments in high-resolution mass spectrometric analyses of new psychoactive substances","volume":"96","author":"Klingberg","year":"2022","journal-title":"Arch Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:40:53Z","timestamp":1778578853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001360","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"2025-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}